MediWound (MDWD) EBT Margin (2014 - 2025)

MediWound (MDWD) recorded quarterly EBT Margin of 417.78% in Q4 2025, down 247.61% quarter-over-quarter from 120.19% in Q3 2025, and down 31331.0% on a YoY basis from N/an in Q4 2024.

MediWound (MDWD) EBT Margin (2014 - 2025) Analysis & Trends

MediWound's EBT Margin history runs 12 years deep, the most recent figure standing at 417.78% for Q4 2025.

  • In Q4 2025, EBT Margin fell 31331.0% year-over-year to 417.78%; the TTM figure through Dec 2025 stood at 217.06% (down 10334.0% YoY), while the FY2025 annual figure was 139.81%, up 935.0% from the prior year.
  • EBT Margin was 417.78% for Q4 2025 at MediWound, down from 120.19% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 26.26% in Q2 2023 to a low of 417.78% in Q4 2025.
  • Historically, EBT Margin has averaged 119.42% across 5 years, with a median of 99.21% in 2021.
  • The sharpest annual moves came in 2023 and 2025: EBT Margin soared 18290 bps in 2023, then tumbled 31331 bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 75.74% in 2021, then climbed by 16 bps to 63.63% in 2022, then surged by 52 bps to 30.4% in 2023, then tumbled by 244 bps to 104.47% in 2024, then tumbled by 300 bps to 417.78% in 2025.
  • The last three EBT Margin figures came in at 417.78% (Q4 2025), 120.19% (Q3 2025), and 342.8% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 6.40%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 41.95%
9 Abivax 94.37 Bn 94.37 Bn - -
10 MediWound 3.70 Mn 3.70 Mn 278,000.00 -417.78%

Historic Data

Download Data
DateValue
Dec 31, 2025 -417.78%
Sep 30, 2025 -120.19%
Jun 30, 2025 -342.80%
Mar 31, 2025 -132.11%
Dec 31, 2024 -104.47%
Sep 30, 2024 -116.67%
Jun 30, 2024 -179.99%
Mar 31, 2024 -75.22%
Dec 31, 2023 -30.40%
Sep 30, 2023 -44.97%
Jun 30, 2023 26.26%
Mar 31, 2023 -97.08%
Dec 31, 2022 -63.63%
Sep 30, 2022 -72.27%
Jun 30, 2022 -156.64%
Mar 31, 2022 -81.35%
Dec 31, 2021 -75.74%
Sep 30, 2021 -101.33%
Jun 30, 2021 -105.06%
Mar 31, 2021 -96.97%